MONTANOVA CAPITAL, LLC bought BNTC
December 18, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 1,515 shares of Benitec Biopharma Inc. at $11.24 per share, a transaction worth $17.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,515
Price
$11.24
Total value
$17.0K
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateDecember 18, 2025
Filing dateDecember 22, 2025
Shares owned after1,821,327
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.